Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,412 | 232 | 78.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,233 | 1 | 21.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biofrontera Inc. | $1,247 | 2 | $0 (2017) |
| ABBVIE INC. | $1,175 | 69 | $0 (2024) |
| LEO Pharma Inc. | $324.35 | 16 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $309.43 | 16 | $0 (2023) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $294.09 | 14 | $0 (2024) |
| Celgene Corporation | $279.44 | 4 | $0 (2018) |
| Mayne Pharma Inc. | $204.20 | 12 | $0 (2019) |
| Allergan, Inc. | $175.71 | 5 | $0 (2022) |
| GENZYME CORPORATION | $164.45 | 9 | $0 (2022) |
| Lilly USA, LLC | $161.88 | 10 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $145.06 | 10 | ABBVIE INC. ($33.21) |
| 2023 | $402.54 | 16 | Arcutis Biotherapeutics, Inc. ($96.77) |
| 2022 | $263.63 | 12 | ABBVIE INC. ($66.18) |
| 2021 | $370.16 | 18 | AbbVie Inc. ($187.06) |
| 2020 | $632.59 | 28 | AbbVie Inc. ($237.27) |
| 2019 | $644.58 | 40 | AbbVie, Inc. ($214.60) |
| 2018 | $864.86 | 50 | AbbVie, Inc. ($200.01) |
| 2017 | $2,322 | 59 | Biofrontera Inc. ($1,247) |
All Payment Transactions
233 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/18/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: FACIAL AESTHETICS | ||||||
| 10/10/2024 | STRATA Skin Sciences, Inc. | XTRAC (Device) | Food and Beverage | In-kind items and services | $2.45 | General |
| Category: Dermatology | ||||||
| 09/11/2024 | STRATA Skin Sciences, Inc. | XTRAC (Device) | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: Dermatology | ||||||
| 05/20/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: Dermatology | ||||||
| 04/23/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: DERMATOLOGY | ||||||
| 03/20/2024 | STRATA Skin Sciences, Inc. | XTRAC (Device) | Food and Beverage | In-kind items and services | $1.74 | General |
| Category: Dermatology | ||||||
| 03/05/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug), Absorica LD | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: Dermatology | ||||||
| 02/21/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: IMMUNOLOGY | ||||||
| 02/14/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | JUBLIA (Drug) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: Podiatry | ||||||
| 01/30/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $21.22 | General |
| Category: Immunology | ||||||
| 12/12/2023 | Arcutis Biotherapeutics, Inc. | — | Food and Beverage | In-kind items and services | $96.77 | General |
| 11/30/2023 | STRATA Skin Sciences, Inc. | XTRAC (Device) | Food and Beverage | In-kind items and services | $22.60 | General |
| Category: Dermatology | ||||||
| 11/28/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: IMMUNOLOGY | ||||||
| 10/13/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.83 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/10/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: IMMUNOLOGY | ||||||
| 09/11/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: Dermatology | ||||||
| 08/24/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $21.03 | General |
| Category: FACIAL AESTHETICS | ||||||
| 05/25/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $32.65 | General |
| Category: Dermatology | ||||||
| 04/12/2023 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $17.67 | General |
| Category: Dermatology | ||||||
| 04/11/2023 | Sun Pharmaceutical Industries Inc. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: Dermatology | ||||||
| 03/14/2023 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $23.13 | General |
| 03/14/2023 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $20.81 | General |
| Category: Immunology | ||||||
| 02/28/2023 | PFIZER INC. | CIBINQO (Drug) | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: Inflammation & Immunology | ||||||
| 02/27/2023 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $22.08 | General |
| Category: Immunology | ||||||
| 01/03/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $20.33 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 165 | 318 | $47,096 | $9,480 |
| 2022 | 6 | 157 | 322 | $43,438 | $8,541 |
| 2021 | 7 | 304 | 565 | $74,237 | $14,471 |
| 2020 | 12 | 475 | 616 | $603,036 | $135,111 |
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 49 | 65 | $17,255 | $3,436 | 19.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 18 | 21 | $7,042 | $1,616 | 23.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 31 | 38 | $7,530 | $1,433 | 19.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 20 | 20 | $6,579 | $1,096 | 16.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 23 | 150 | $2,960 | $775.78 | 26.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 13 | 13 | $3,904 | $722.80 | 18.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 11 | 11 | $1,827 | $400.59 | 21.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 47 | 57 | $15,317 | $3,289 | 21.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 38 | 46 | $9,029 | $1,583 | 17.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 19 | 19 | $5,820 | $1,067 | 18.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 12 | 14 | $4,694 | $1,025 | 21.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 16 | 16 | $5,297 | $795.34 | 15.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 25 | 170 | $3,282 | $782.55 | 23.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 87 | 104 | $25,344 | $5,091 | 20.1% |
| 17000 | Destruction of skin growth | Office | 2021 | 67 | 75 | $14,585 | $2,502 | 17.2% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 17 | 23 | $7,649 | $1,740 | 22.7% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 34 | 34 | $10,955 | $1,700 | 15.5% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 23 | 23 | $6,971 | $1,323 | 19.0% |
| 17003 | Destruction of 2-14 skin growths | Office | 2021 | 56 | 283 | $5,217 | $1,188 | 22.8% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 20 | 23 | $3,516 | $926.23 | 26.3% |
| 17311 | Removal and microscopic examination of growth of the head, neck, hands, feet, or genitals (first stage, up to 5 tissue blocks) | Office | 2020 | 114 | 132 | $260,289 | $66,410 | 25.5% |
| 17313 | Removal and microscopic examination of growth of the trunk, arms, or legs (first stage, up to 5 tissue blocks) | Office | 2020 | 38 | 40 | $73,900 | $19,624 | 26.6% |
| 17312 | Removal and microscopic examination of growth of the head, neck, hands, feet, or genitals | Office | 2020 | 35 | 55 | $64,961 | $17,125 | 26.4% |
| 13132 | Repair of wound (2.6 to 7.5 centimeters) of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, and/or feet | Office | 2020 | 62 | 69 | $98,103 | $13,020 | 13.3% |
| 13121 | Repair of wound (2.6 to 7.5 centimeters) of scalp, arms, and/or legs | Office | 2020 | 49 | 51 | $65,265 | $8,990 | 13.8% |
About Dr. Keith Haar, MD
Dr. Keith Haar, MD is a MOHS-Micrographic Surgery healthcare provider based in Peoria, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1902852320.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Keith Haar, MD has received a total of $5,645 in payments from pharmaceutical and medical device companies, with $145.06 received in 2024. These payments were reported across 233 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($4,412).
As a Medicare-enrolled provider, Haar has provided services to 1,101 Medicare beneficiaries, totaling 1,821 services with total Medicare billing of $167,603. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Practice Information
- Specialty MOHS-Micrographic Surgery
- Other Specialties Dermatology
- Location Peoria, AZ
- Active Since 05/26/2006
- Last Updated 03/20/2023
- Taxonomy Code 207ND0101X
- Entity Type Individual
- NPI Number 1902852320
Products in Payments
- Ameluz (Drug) $1,247
- Humira (Biological) $598.66
- SKYRIZI (Biological) $392.24
- Otezla (Drug) $279.44
- COSENTYX (Biological) $257.03
- ENSTILAR (Drug) $229.73
- DORYX (Drug) $204.20
- TALTZ (Drug) $161.88
- BOTOX COSMETIC (Biological) $138.93
- ILUMYA (Biological) $111.34
- DUPIXENT (Drug) $100.16
- Enbrel (Biological) $85.42
- Avar (Drug) $81.99
- DUPIXENT (Biological) $76.42
- SILIQ (Drug) $73.82
- STELARA (Biological) $67.95
- HUMIRA (Biological) $67.11
- Sotyktu (Drug) $61.31
- RINVOQ (Biological) $59.76
- BLU-U (Medical Supply) $59.66
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
MOHS-Micrographic Surgery Doctors in Peoria
Caroline Carr, M.d, M.D
MOHS-Micrographic Surgery — Payments: $4,555
Drew Klug, M.d, M.D
MOHS-Micrographic Surgery — Payments: $4,329
Dr. Vernon Mackey, D.o, D.O
MOHS-Micrographic Surgery — Payments: $4,068
Dr. Joshua Kentosh, D.o, D.O
MOHS-Micrographic Surgery — Payments: $775.80